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The immunoreactivity of human low-molecular-mass kininogen from Cohn plasma fraction IV was investi- 
gated after deglycosylations and carbohydrate modifications by radioimmunoassay using the conformation- 
specific antiserum. Removal of all sialic acids, 44% of amino sugars and 63% of neutral sugars did not 
alter the immunoreactivity of the protein but the periodate-treated concanavalin A fractions showed strik- 
ingly diminished immunoreactivity. A conformational change could account for the observed effect of 
periodate on the decreased reactivity of the protein in radioimmunoassay. Externally added carbohydrates 
had no effect on immunoreactivity. The results suggest hat the carbohydrate part of kininogen is not in- 
volved in the immunoreactivity although it accounts for the observed lectin-binding heterogeneity. 
Carbohydrate Glycoprotein Kininogen 
1. INTRODUCTION 
Two types of kininogens, a high-M, (M 120000) 
and a low-M, (Mr 50000-70000) form exist in 
human plasma [l]. Also, a kinin-free low-M, 
kininogen (A4r 60000) from Cohn plasma fraction 
IV, HC antigen, has been isolated and character- 
ized [2]. Both native kininogens are glycoproteins 
and the precursors of the vasoactive kinins. The 
charge heterogeneities of the 2 native plasma 
kininogens have been investigated [3,4]. The low- 
A4* kininogen occurs in several immunoreactive 
isoelectric forms with the main component at pZ 
4.5-4.6 and that of high-M, kininogen at pZ 4.7. 
The different isoelectric pattern of HC antigen with 
a low pZ of 4.2-4.4 is suggested to result from the 
structural variations in the carbohydrate part of 
the molecule [2,5]. Two different carbohydrate 
structures of HC antigen obtained after con- 
canavalin A (Con A) chromatography show, 
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however, identical isoelectric patterns [6]. This in- 
dicates that the lectin-binding heterogeneity is not 
charge dependent. 
Here we investigate the role of carbohydrates in 
the immunoreactivity of Hc antigen by removing 
or modifying the sugar residues. Exoglycosidase 
treatments, addition of carbohydrates and 
chemical modifications are performed. The an- 
tigenicity of the protein is measured by radioim- 
munoassay (RIA) using antisera against the con- 
formational determinants of HC antigen [7]. 
2. MATERIALS AND METHODS 
2.1. Preparation of HC antigen 
I-k antigen was purified from freshly 
precipitated Cohn plasma fraction IV [2]. Im- 
munological purity was achieved with antibody- 
specific polymers by removing impurities of wHS- 
glycoprotein, ceruloplasmin and albumin [8]. 
Quantitative determinations of immunoreactive 
kininogen were performed by single radial im- 
munodiffusion [9,10]. Protein was measured by 
AZ80 using Airi = 7 for pure kininogen. 
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2.2. Preparation of antiserum 
Antiserum against HC antigen was prepared in 
rabbits using the immunologically pure antigen 
containing the conformation-dependent deter- 
minants of the native kininogen [7]. The associa- 
tion constant of this antiserum against the native 
kininogen was 3.8 x lo9 M-‘. 
2.3. RIA 
Radiolabelling of Hc antigen to a specific activi- 
ty of 6O&i/pg was performed according to 
Greenwood et al. [l I] using chloramine T. Free 
Nalz51 (IMS 30, Amersham) was removed by gel 
filtration on Sephadex G-25 using 50 mM sodium 
phosphate buffer, pH 7.5, and the column was 
washed with 1% bovine albumin (RIA grade, 
Sigma) before use. The radioiodinated protein was 
diluted 1: 10 in 50 mM sodium phosphate buffer, 
pH 7.5, containing 0.25% bovine albumin, 0.15 M 
NaCl and 0.01% NaN3 and stored at - 70°C. The 
antiserum was diluted 1:20000 in the same buffer 
for RIA [7,12]. 
2.4. Affinity chromatography on lectins 
Columns of Con A-Sepharose 4B were used as 
in [5]. Ricinus communis agglutinin (RCAr) was 
isolated from castor beans, coupled to CNBr- 
activated Sepharose 4B and the affinity 
chromatography run as described [6]. 
2.5. Exoglycosidase treatments of kininogen 
The digestion of 950 rg immunoreactive HC an- 
tigen was performed using 1.5 units neuraminidase 
(Clostridium perfringens, type VI, Sigma), 1 .O unit 
B--N-acetylglucosaminidase (jack beans, Sigma), 
0.8 unit u-mannosidase (jack beans, type III, 
Sigma) and 0.8 unit P-galactosidase (Aspergillus 
niger, grade V, Sigma) in 1 ml of 50 mM sodium 
citrate buffer, pH 5.0, at 37°C for 72 h. The 
released sialic acids, neutral sugars and amino 
sugars were quantitated [13-151 after dialysis. The 
neuraminidase treatment of 3.0 mg Hc antigen 
was performed in 0.1 M acetate buffer, pH 5.0, 
with 3 units enzyme for 2 h at 37°C. 
2.6. The added monosaccharides in RIA 
1.8 ng N-acetylneuraminic acid (type IV, 
Sigma), 1.0 ng D-galactose (G-0750, Sigma) and 
0.5 ng D-mannose (M-4625, Sigma) were separate- 
ly added to a solution of 41 ng Hc antigen in 200 ~1 
142 
of 50 mM sodium phosphate buffer, pH 7.5,0.2(‘/0 
gelatine, 0.15 M NaCl and 0.01% NaN3 and the 
solutions were analyzed in RIA. 
2.7. The periodate treatment 
The Con A nonreactive and reactive fractions 
(200 pg protein from both pools) were incubated in 
3 ml of 20 mM sodium metaperiodate at 4°C in 
the dark for 6 h and dialyzed against 10 mM 
sodium phosphate, 0.15 M NaCl, pH 7.0, 
overnight. 
3. RESULTS AND DISCUSSION 
The Con A reactive and non-reactive fractions 
of Hc antigen previously showed identical dose- 
response curves in RIA [6]. Here we treated both 
Con A fractions with periodate and applied them 
to RIA. Con A is known to distinguish various 
branching patterns of mannose [16,17] and the 
periodate treatment of glycoproteins results in 
selective modification of sialic acids [18]. Im- 
munoreactivity of the periodate-treated Con A 
reactive and non-reactive fractions was reduced to 
34 and 17% of the untreated HC antigen when 
tested in RIA with the conformationally dependent 
antiserum (fig.1). This indicates that the im- 
10 ng BKG 100 
Fig.1. Dose-response curves for native Hc antigen (0) 
and the Con A reactive (0) and non-reactive (0) 
fractions of Hc antigen after periodate treatment using 
conformationally dependent antiserum. BKG, Hc 
antigen. 
Volume 191, number 1 FEBS LETTERS October 1985 
munoreactivity of Hc antigen is greatly influenced 
by the modification of sialic acids. 
HC antigen was next incubated with 
neuraminidase and the product was separated by 
R. communis lectin. The Ricinus-reactive fraction 
was submitted to RIA. By using the reactive com- 
ponent we obtained a fraction free of terminal 
sialic acids since Ricinus lectin is known to be 
specific for terminal galactose residues [19]. The 
immunoreactivity of HC antigen was not influ- 
enced by the complete removal of sialic acids as 
parallel and identical dose-response curves were 
obtained in RIA (fig.2). 
The decrease in immunoreactivity seen after 
periodate treatment (fig.l), however, seems to be 
independent of sialic acids since no deterioration 
of immunoreactivity was detected after treatment 
with neuraminidase (fig.2). This supports a con- 
cept of a conformational change in both Con A 
fractions ‘caused by the periodate treatment. 
The influence of the total removal of sialic acids 
and partial removal of amino sugars and neutral 
sugars on immunoreactivity was investigated by 
using a mixture of exoglycosidases. All sialic acids 
but only 44% of amino sugars and 63% of neutral 
sugars could be removed. The exoglycosidases 
remove terminal non-reducing monosaccharides 
but their activity on intact glycoproteins is more 







Fig.2. Displacement curves for the native (0) and the 
desialylated (0) Hc antigen obtained after affinity 
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Fig.3. Immunoreactivity of the native (0) and partially 
deglycosylated (*) Hc antigen. 950 pg immunoreactive 
Hc antigen was treated with a mixture of 
exoglycosidases. 
tigen are apparently masked by the polypeptide 
core and are resistant to cleavage. However, the 
native and enzyme-treated proteins showed iden- 
tical dose-response curves in RIA (fig.3). This in- 
dicates that the antigenic sites of HC antigen are 
located in the polypeptide part of the molecule and 
that sialic acids and 44% of amino sugars and 63% 
of neutral sugars do not affect the antigenicity of 
the protein. It cannot, however, be excluded that 
the remaining carbohydrate side chains play a role 
in the conformation of the protein and in its 
immunoreactivity. 
The involvement of externally added monosac- 
charides in the immunoreactivity of Hc antigen 
was further studied by RIA. The added amounts of 
sugars were those normally present in the intact 
protein [6]. However, 
tivity was seen (fig.4). 
no effect on immunoreac- 
IO ng BKG 100 
Fig.4. Dose-response curves for the native Hc antigen 
(o) and after addition of sialic acid (*), galactose (0) 
and mannose (0). 
143 
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In conclusion, HC antigen had been previously 
shown to have an extensive charge heterogeneity 
[2] which was suggested to be due to the variations 
of the carbohydrate part of the molecule. This 
study indicates that sialic acids are not essential for 
the antigen-antibody reaction of HC antigen. A 
large portion of amino sugars and neutral sugars 
are neither involved in the immunoreactivity of the 
protein although they seem to be the main cause of 
the previously found charge heterogeneity. Our 
results confirm that the immunoreactivity of HC 
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